M. Siraç Dilber

2.1k total citations
42 papers, 1.6k citations indexed

About

M. Siraç Dilber is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, M. Siraç Dilber has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Genetics and 16 papers in Oncology. Recurrent topics in M. Siraç Dilber's work include Virus-based gene therapy research (17 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (12 papers). M. Siraç Dilber is often cited by papers focused on Virus-based gene therapy research (17 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (12 papers). M. Siraç Dilber collaborates with scholars based in Sweden, Finland and Colombia. M. Siraç Dilber's co-authors include Alar Aints, Smith Rjh, Gösta Gahrton, Hans‐Gustaf Ljunggren, Evren Alici, Birger Christensson, Outi Hovatta, Mari Gilljam, Heli Skottman and Hayrettin Guvén and has published in prestigious journals such as Blood, FEBS Letters and Human Molecular Genetics.

In The Last Decade

M. Siraç Dilber

42 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Siraç Dilber Sweden 21 749 715 578 432 281 42 1.6k
Stanley Chaleff United States 7 679 0.9× 437 0.6× 468 0.8× 247 0.6× 361 1.3× 8 1.5k
Johannes C.M. van der Loo United States 18 438 0.6× 868 1.2× 418 0.7× 731 1.7× 384 1.4× 32 1.7k
James G. McArthur United States 18 1.5k 2.0× 802 1.1× 885 1.5× 684 1.6× 106 0.4× 30 2.6k
Ikumi Katano Japan 18 934 1.2× 312 0.4× 482 0.8× 292 0.7× 168 0.6× 39 1.5k
Shao‐An Xue United Kingdom 26 1.4k 1.8× 814 1.1× 1.3k 2.2× 652 1.5× 109 0.4× 46 2.6k
Klaus Kühlcke Germany 16 421 0.6× 1.1k 1.6× 622 1.1× 1.1k 2.5× 178 0.6× 27 1.8k
Blythe Sather United States 19 1.1k 1.5× 671 0.9× 733 1.3× 442 1.0× 177 0.6× 29 2.0k
Marina Radrizzani Italy 19 542 0.7× 609 0.9× 509 0.9× 335 0.8× 75 0.3× 38 1.3k
Shoshana Morecki Israel 24 1.0k 1.4× 909 1.3× 774 1.3× 955 2.2× 777 2.8× 72 2.4k
Christopher J. Lees United States 16 1.3k 1.7× 382 0.5× 329 0.6× 203 0.5× 715 2.5× 23 1.9k

Countries citing papers authored by M. Siraç Dilber

Since Specialization
Citations

This map shows the geographic impact of M. Siraç Dilber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Siraç Dilber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Siraç Dilber more than expected).

Fields of papers citing papers by M. Siraç Dilber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Siraç Dilber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Siraç Dilber. The network helps show where M. Siraç Dilber may publish in the future.

Co-authorship network of co-authors of M. Siraç Dilber

This figure shows the co-authorship network connecting the top 25 collaborators of M. Siraç Dilber. A scholar is included among the top collaborators of M. Siraç Dilber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Siraç Dilber. M. Siraç Dilber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dilber, M. Siraç, et al.. (2025). Protective effect of adenosine triphosphate against cisplatin-induced necrotic and degenerative oral mucositis in rats. Journal of Applied Oral Science. 33. e20250007–e20250007. 3 indexed citations
2.
Barkholt, Lisbeth, Evren Alici, Tolga Sütlü, et al.. (2009). Safety Analysis of Ex Vivo -Expanded NK and NK-Like T Cells Administered to Cancer Patients: a Phase I Clinical Study. Immunotherapy. 1(5). 753–764. 89 indexed citations
3.
Alici, Evren, Tolga Sütlü, & M. Siraç Dilber. (2009). Retroviral Gene Transfer into Primary Human Natural Killer Cells. Methods in molecular biology. 506. 127–137. 11 indexed citations
4.
Unger, Christian, Ulrika Felldin, Agneta Nordenskjöld, M. Siraç Dilber, & Outi Hovatta. (2008). Derivation of Human Skin Fibroblast Lines for Feeder Cells of Human Embryonic Stem Cells. Current Protocols in Stem Cell Biology. 5(1). Unit 1C.7–Unit 1C.7. 12 indexed citations
5.
Unger, Christian, Heli Skottman, Pontus Blomberg, M. Siraç Dilber, & Outi Hovatta. (2008). Good manufacturing practice and clinical-grade human embryonic stem cell lines. Human Molecular Genetics. 17(R1). R48–R53. 167 indexed citations
6.
Unger, Christian, Radim Černý, Lars Ährlund‐Richter, et al.. (2008). Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: A dose‐dependent effect of osterix over‐expression. Journal of Cellular Physiology. 218(2). 323–333. 18 indexed citations
7.
Alici, Evren, Tolga Sütlü, Alar Aints, et al.. (2007). Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model. Experimental Hematology. 35(12). 1839–1846. 37 indexed citations
8.
Treschow, Alexandra, et al.. (2007). OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h. Gene Therapy. 14(22). 1564–1572. 7 indexed citations
9.
Guimarães, Fernando, Hayrettin Guvén, Daria Donati, et al.. (2006). Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice. Leukemia. 20(5). 833–839. 20 indexed citations
10.
Skottman, Heli, M. Siraç Dilber, & Outi Hovatta. (2006). The derivation of clinical‐grade human embryonic stem cell lines. FEBS Letters. 580(12). 2875–2878. 36 indexed citations
11.
Alici, Evren, et al.. (2005). Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells. Experimental Hematology. 33(2). 159–164. 37 indexed citations
12.
Christensson, Birger, et al.. (2005). Genetically Modified Autoactivated Cells Expressing Intracellular Forms of GM‐CSF as a Model for Regulated Administration of Cytokines. Scandinavian Journal of Immunology. 62(5). 429–436. 2 indexed citations
13.
14.
Carlens, Stefan, Olle Ringdén, J Aschan, et al.. (2002). Cytolytic T Cell Reactivity to Epstein-Barr Virus Is Lost During In Vitro T Cell Expansion. Journal of Hematotherapy & Stem Cell Research. 11(4). 669–674. 9 indexed citations
15.
Carlens, Stefan, Mari Gilljam, Benedict J. Chambers, et al.. (2001). A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cells. Human Immunology. 62(10). 1092–1098. 112 indexed citations
16.
Lundgren, Anna, Alar Aints, Abdalla Mohamed, et al.. (2001). Proximal promoter of the murine syndecan‐1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells. American Journal of Hematology. 67(1). 20–26. 5 indexed citations
17.
18.
Aints, Alar, M. Siraç Dilber, & Smith Rjh. (1999). Intercellular spread of GFP-VP22. The Journal of Gene Medicine. 1(4). 275–279. 39 indexed citations
19.
Carlens, Stefan, J Aschan, Mats Remberger, M. Siraç Dilber, & Olle Ringdén. (1999). Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia. Bone Marrow Transplantation. 24(6). 629–635. 47 indexed citations
20.
Dilber, M. Siraç, Bo Björkstrand, Smith Rjh, et al.. (1995). Retroviral‐mediated gene transfer into human bone marrow stromal cells: Studies of efficiency and in vivo survival in SCID mice. European Journal Of Haematology. 55(5). 302–306. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley Chaleff Breakdown of academic impact, for papers by Johannes C.M. van der Loo Breakdown of academic impact, for papers by James G. McArthur Breakdown of academic impact, for papers by Ikumi Katano Breakdown of academic impact, for papers by Shao‐An Xue Breakdown of academic impact, for papers by Klaus Kühlcke Breakdown of academic impact, for papers by Blythe Sather Breakdown of academic impact, for papers by Marina Radrizzani Breakdown of academic impact, for papers by Shoshana Morecki Breakdown of academic impact, for papers by Christopher J. Lees
Rankless by CCL
2026